Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Nanoscale|September 8, 2025
Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulationKunfeng Zhang, Mingze Li, Dezhi Sui, et al.
ACS Nano|January 31, 2023
Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular DiseasesShuo Wang, Yuequan Wang, Xiaoxue Lai, et al.
International Journal of Pharmaceutics|March 22, 2022
Neutrophils as emerging immunotherapeutic targets: Indirect treatment of tumors by regulating the tumor immune environment based on a sialic acid derivative-modified nanocomplex platformMeng Chen, Wenjing Wu, Shuo Wang, et al.
Molecular Pharmaceutics|November 6, 2018
Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug DeliveryMingqi Liu, Xiang Luo, Qiujun Qiu, et al.
Drug Delivery|May 24, 2018
Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatmentXiang Luo, Ling Hu, Huangliang Zheng, et al.
AAPS Pharmscitech|September 14, 2018
Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent SolubilityQiujun Qiu, Mei Lu, Cong Li, et al.
Biomaterials|February 26, 2022
Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacyMin Liu, Jie Li, Dan Zhao, et al.
International Journal of Pharmaceutics|October 3, 2020
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapyXueying Tang, Dezhi Sui, Mingqi Liu, et al.
International Journal of Pharmaceutics|June 11, 2018
Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activityXiang Luo, Mingqi Liu, Ling Hu, et al.
Molecular Pharmaceutics|December 21, 2019
Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular WeightsMengyang Liu, Yanyi Chu, Huan Liu, et al.
Pageof 18